Structured Self-Rated Response to Iontophoresis with Verapamil and Dexamethasone in Peyronie’s Disease

Table 4

Self-report on quality of sex and erectile and sexual functions prior to EMDA therapy among men who either expressed benefit or not improved using the treatment.

Sexual functions	Responders (%)	Nonresponders (%)	𝑃 value
Capable to sexual intercourse	50.0	83.0	0.196
Able to ejaculate	87.5	100.0	1.0
Rapid ejaculation	50.0	16.7	0.196
Painful sex for partner	25.0	50.0	0.329
Difficulty with penetration	45.9	100.0	0.061
Due to curvature	25.0	66.6	0.141
Due to hinge effect	4.2	16.5	0.366
Due to lack of firmness	16.7	16.9	1.0
Normal sexual desire	45.8	66.7	0.651
High sexual desire	4.2	33.3	0.094
Low sexual desire	50.0	0.0	0.024
Erectile score (0–10), mean ± SD	7.6±0.7	7.7±0.8	0.754
Cases with 10/10	37.5	66.7	0.360
Maintain erection after penetration	66.7	50	0.641
Morning erection	54.2	50	1.0

Bold refers to significant results.